MedTrace Logo

Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

NCT06263192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342

Last updated 2024-02-16

No results posted yet for this study

Summary

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels \> and \< 1.1 ng/mL.

Conditions

  • Infertility, Female
  • Anti-Mullerian Hormone Deficiency

Interventions

PROCEDURE

Intrauterine insemination

Intrauterine insemination with sperm donors

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Jose Antonio Moreno

    lead OTHER

Principal Investigators

  • Miguel Angel Checa · Fertty International

Eligibility

Min Age
25 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-12-01
Completion
2023-05-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06263192 on ClinicalTrials.gov